Trial Profile
Clinical Trials Insight: 700025377
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 30 Jul 2008
Price :
$35
*
At a glance
- Drugs Epinastine (Primary)
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors Inspire Pharmaceuticals
- 29 Nov 2007 Status changed from planning to initiated.
- 27 Jul 2007 New trial record.